Capturing cancer
Nature Nanotechnology
September 30, 2013
Cells that help to drive the spread of cancer throughout the body can be detected with high sensitivity in early-stage cancer patients using a novel nanomaterial-based chip. The findings, reported online this week in Nature Nanotechnology, suggest that the isolation and recovery of these cells could inform the diagnosis and treatment of cancer patients.
Sunitha Nagrath and colleagues have developed a graphene oxide-based chip that can capture rare circulating tumour cells that detach from the existing tumour and can get carried in the bloodstream to other tissues, thus spreading cancer. Using their nanoscale device, the researchers can select for these cancerous cells from healthy blood cells and analyse them for cancer-related biomarkers. The team believes that these biomarkers will provide insights into the character of the cancer and potentially influence the management of the disease.
doi: 10.1038/nnano.2013.194
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports